PharmaEssentia Corporation (TPE:6446)
1,195.00
+35.00 (3.02%)
Jun 25, 2026, 1:30 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 444.1 billion as of June 25, 2026. Its market cap has increased by 166.94% in one year.
Market Cap
444.10B
Enterprise Value
420.88B
Revenue
17.50B
Ranking
n/a
PE Ratio
74.86
Stock Price
1,195.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 444.10B, an increase of 1,027.60%. That is a compound annual growth rate of 21.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 444.10B | 155.48% |
| Dec 31, 2025 | 173.83B | -15.09% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 53.43B |
| Lotus Pharmaceutical | 49.67B |
| Center Laboratories | 28.26B |
| TTY Biopharm Company | 18.55B |
| Handa Pharmaceuticals | 16.45B |
| ScinoPharm Taiwan | 15.97B |
| Synmosa Biopharma | 15.54B |
| YungShin Global Holding | 14.41B |